Russian Cancer Research Center NN Blokhin
In research, Russian Cancer Research Center NN Blokhin stands highest in Medicine (#9,796 of 10,443 worldwide) and Health Sciences (#11,464 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 14.9× its share of world research.
- World rank, 2022–2025
- #21,994 of 28,054 · #15,914 all time
- Rank in Russia
- #686 of 1,062
- Research works
- 1.8k ▼ 60% vs 2013–17
- Citations
- 21k 12.0 per fractional work
- Top-10% rate
- 4.9% record average 16.5%
- Open access
- 44% world 28%
What is Russian Cancer Research Center NN Blokhin known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,796 of 10,443 | 4.2% | 92 | #6776 | |
| Health SciencesDomain | #11,464 of 11,982 | 4.3% | 93 | #8938 |
Each strip is that field’s whole ranked pool, with the notch where Russian Cancer Research Center NN Blokhin sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Russian Cancer Research Center NN Blokhin specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.9× the share of its output that it takes of world research.
- OncologySubfield · 22.8 works15×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.8×
- Immunology and Microbiology 3.6×
- Medicine 3.5×
- Pharmacology, Toxicology and Pharmaceutics 2.9×
- Chemistry 1.2×
- Dentistry 0.9×
- Nursing 0.5×
- Materials Science 0.3×
- Health Professions 0.3×
- Economics, Econometrics and Finance 0.2×
- Physics and Astronomy 0.2×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
- Neuroscience 0.0×
- Business, Management and Accounting 0.0×
- Mathematics 0.0×
Who are the top researchers at Russian Cancer Research Center NN Blokhin?
Ranked on the composite score, В. А. Горбунова, Mikhail Lichinitser and Lev Demidov lead among researchers whose main affiliation is Russian Cancer Research Center NN Blokhin.
- 1 В. А. Горбунова Russia · #43,488 worldwide 453 citations · 31 works
- 2 Mikhail Lichinitser Russia · #101,691 worldwide 233 citations · 25 works
- 3 Lev Demidov Russia · #126,258 worldwide 185 citations · 59 works
- 4 В. В. Бредер Russia · #146,245 worldwide 123 citations · 38 works
- 5 S. Tjulandin Russia · #171,623 worldwide 124 citations · 35 works
- 6 Д. В. Комов Russia · #189,855 worldwide 599 citations · 17 works
- 7 Э. Э. Топузов Russia · #378,200 worldwide 57 citations · 17 works
- 8 Guzel Mukhametshina Russia · #498,198 worldwide 92 citations · 15 works
- 9 Sergei Tjulandin Russia · #515,753 worldwide 141 citations · 67 works
- 10 К. П. Лактионов Russia · #518,714 worldwide 1 citations · 27 works
Which keywords describe research at Russian Cancer Research Center NN Blokhin?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Immunotherapy, Clinical Practice Guidelines, Cancer, Breast Cancer, Tumor Microenvironment and Survival Analysis.
- Apoptosis
- Lymph Node Dissection
- PD-1 and PD-L1
- Gastric Cancer
- Therapeutic Targets
- Adjuvant Therapy
- Genomic Instability
- Genetic Pathogenesis
- Clinical Trials
- Metastasis
- Molecular Subtypes
- Genetic Mutations
- Lymphoma
- Molecular Characterization
- Radiotherapy
- PET Imaging
- Tumor Microenvironment
- Breast Cancer
- Cancer
- Prognostic Factors
- Chemotherapy
- Immunotherapy
- Clinical Practice Guidelines
- Inflammation
- Survival Analysis
- Targeted Therapy
- Rituximab
- Molecular Profiling
- Neoadjuvant Therapy
- Gene Expression Profiling
- Cancer Therapy
- Classification
- Metastatic Breast Cancer
- Hodgkin's Lymphoma
- Precision Medicine
- Surgical Management
- Endoscopic Resection
- Immune Checkpoint Blockade
- Neoadjuvant Chemotherapy
- Metastatic Gastric Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy20▲ 21×21 topics
- Prognostic Factors14▲ 23×14 topics
- Immunotherapy11▲ 12×16 topics
- Cancer10▲ 5.4×30 topics
- Clinical Practice Guidelines9▲ 12×9 topics
- Breast Cancer8▲ 25×8 topics
- Inflammation8▲ 2.8×34 topics
- Tumor Microenvironment8▲ 13×8 topics
- Survival Analysis6▲ 18×5 topics
- PET Imaging6▲ 27×4 topics
- Targeted Therapy6▲ 20×5 topics
- Radiotherapy6▲ 11×11 topics
- Rituximab6▲ 28×2 topics
- Molecular Characterization6▲ 23×5 topics
- Molecular Profiling6▲ 42×3 topics
- Lymphoma6▲ 25×4 topics
- Neoadjuvant Therapy5▲ 16×5 topics
- Genetic Mutations5▲ 8.1×11 topics
- Gene Expression Profiling4▲ 40×2 topics
- Molecular Subtypes4▲ 38×3 topics
- Cancer Therapy4▲ 5.4×15 topics
- Metastasis4▲ 8.8×10 topics
- Classification4▲ 6.5×2 topics
- Clinical Trials4▲ 4.3×5 topics
- Metastatic Breast Cancer4▲ 52×2 topics
- Genetic Pathogenesis4▲ 53×1 topic
- Hodgkin's Lymphoma4▲ 53×1 topic
- Genomic Instability4▲ 25×3 topics
- Precision Medicine4▲ 6.0×6 topics
- Adjuvant Therapy4▲ 21×2 topics
- Surgical Management4▲ 6.5×7 topics
- Therapeutic Targets4▲ 17×5 topics
- Endoscopic Resection4▲ 26×2 topics
- Gastric Cancer4▲ 23×2 topics
- Immune Checkpoint Blockade4▲ 23×1 topic
- PD-1 and PD-L14▲ 23×1 topic
- Neoadjuvant Chemotherapy3▲ 29×2 topics
- Lymph Node Dissection3▲ 39×1 topic
- Metastatic Gastric Cancer3▲ 39×1 topic
- Apoptosis3▲ 7.5×7 topics
Which research topics does Russian Cancer Research Center NN Blokhin publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes and Colorectal Cancer Treatments and Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 3 works
- 4 Colorectal Cancer Treatments and Studies Oncology 3 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 6 Cancer Genomics and Diagnostics Cancer Research 2 works
- 7 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 8 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 2 works
- 10 HER2/EGFR in Cancer Research Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Russian Cancer Research Center NN Blokhin's research output changed?
Output in 2018–2022 was 60% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Moscow
- Russian Academy of Sciences
- Lomonosov Moscow State University
- National Research University Higher School of Economics
- Peoples' Friendship University of Russia
- Sechenov University
- Bauman Moscow State Technical University
- Kurchatov Institute
- N.D. Zelinsky Institute of Organic Chemistry
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.